September 7-9, 2023
Essen / Germany + ONLINE
PROGRAM ▪ PROGRAMM
PROGRAMM - der Infoflyer für Sie:
Download PDF
THURSDAY, SEPTEMBER 7, 2023
PRE-PROGRAM: BREAST CANCER
ANZEICHNUNGSKURS BRUSTCHIRURGIE „MALEN NACH ZAHLEN“
09.00 - 09.20 am
Verschiedene Reduktionstechniken – Wann und Wie am besten anzuwenden?
S. Kümmel
09.20 - 09.40 am
Die komplizierte BET: Untere Quadranten und No Man´s Land – Wie kann man das geschickt lösen?
H. Rotthaus
09.40 - 10.00 am
Die richtige Implantat- und Lageauswahl bei Rekonstruktion sowie ästhetischer Augmentation
M. Warm
10.00 - 10.20 am
Brust-OP beim Mann: von Gynäkomastie über Free Nipple bis zur Transgender-OP
S. Kümmel
10.20 - 10.40 am
Tipps und Tricks vor, während und nach Brustoperationen – von Antibiose über PRP bis Taping
E. Bensmann
10.40 - 11.00 am
// BREAK
SATELLITE SYMPOSIUM
Chair: S. Kümmel
11.00–12.00 pm
Antibody-Drug Conjugates: A New Era of Treatment for HER2- Breast Cancer
The Potential of ADCs in Breast Cancer
F. Marmé
Real World Experience and Therapy Management with Sacituzumab govitecan
M. Thill
With the kind support of GILEAD Sciences GmbH
INTERNATIONAL SESSION – RECONSTRUCTION
Chair: F. Reyal, P. G. Cordeiro, S. Kümmel
12.00 - 12.15 pm
Locally Advanced Breast Cancer – What Surgery is Possible and What Makes Sense?
F. Reyal
12.15 - 12.30 pm
Pre and Subpectoral DTI (Direct to Implant) Reconstruction: Tipps, Tricks, Indications
A. Rancati
12.30 - 12.45 pm
Microsurgery for Breast Reconstruction: Is there a Limit?
B. Behr
12.45 - 01.00 pm
Pre-Pectoral Breast Reconstruction – Surgical Approach and Indication
P. G. Cordeiro
01.00 - 01.20 pm
Live Panel Discussion
S. Kümmel, F. Reyal, P. G. Cordeiro, A. Rancati, B. Behr
MASTER OF DISASTER – HOW TO SOLVE PROBLEMS
Chair: J.-U. Blohmer, M. Thill, M. Lehnhardt
01.30 - 01.40 pm
Difficult Cases and How I Solved Them
H. Harrach
01.40 - 01.55 pm
Tubular Breast – Surgical Pathways
K. Brunnert
01.55 - 02.10 pm
Implant Rupture: How to Solve and What We should do with Silicone at Lymph Nodes?
M. Thill
02.10 - 02.25 pm
Symmastia after Implants – What are the Options for Correction?
J.-U. Blohmer
02.25 - 02.35 pm
Live Discussion and Live Chat
02.35 - 03.00 pm
// BREAK
SATELLITE SYMPOSIUM
Chair: P. Harter, S. Kümmel
What’s New? – Current Developments in Breast and Gynaecological Cancers
03.00 - 03.30 pm
Current Challenges in Systemic Therapies of HER2-Negative Breast Cancer
O. Gluz
03.30 - 04.00 pm
New Treatment Strategies in Gynaecological Cancers
B. Ataseven
With the kind support of AstraZeneca GmbH
PRE-PROGRAM: GYNECOLOGIC ONCOLOGY
SURGICAL WORKSHOP GYNECOLOGIC ONCOLOGY – PICTURES AND VIDEOS
Chair: Chair: P. Harter, S. Mahner
04.00 - 04.20 pm
Plastic Reconstruction in Vulvar Cancer Surgery
S. Mahner
04.20 - 04.40 pm
Technique of Radical Hysterectomy
L. M. Chiva de Agustin
04.40–05.00 pm
Technique of HIPEC
A. Fagotti
05.00 - 05.20 pm
Bowel Anastomosis – How to Check to Avoid Leakage
O. Zivanovic
05.20 - 05.40 pm
Endoscopic Lymphadenectomy
M. Z. Muallem
05.40 - 06.00 pm
Surgical Management Lesser Omentum, Coeliac Trunk and Stomach
C. Fotopoulou
06.00 - 06.20 pm
Pelvic Exenteration
N. R. Abu-Rustum
06.20 - 06.40 pm
The First 7 Recommendations to Improve Peri-OP Management
S. Schneider
FRIDAY, SEPTEMBER 8, 2023
MAIN PROGRAM: LIVE SURGERY + GYNECOLOGIC ONCOLOGY
WAKE UP SESSION PRE-SURGERY
08.00 - 08.20 am
Ongoing Trials in Gynecologic Oncology
F. Heitz
08.20 - 12.20 am
LIVE SURGERY
THEATER 1:
Breast Surgery – New OP Procedures Tips and Tricks for Solving Complications and Difficult Cases
Surgeons: J.-U. J.-U. Blohmer, M. Warm, E. Bensmann, H. Rotthaus, S. Skoblinow, M. Reinisch, B. Behr, O. Chiari, H. Harrach, S. Kümmel
Chair: F. Reyal, K. Brunnert, M. Thill
THEATER 2:
Gynecologic Oncology
Surgeons: P. Harter, M. Z. Muallem, G. Aletti
Chair: A. du Bois, N. R. Abu-Rustum, L. M. Chiva de Agustin
12.20 - 01.00 pm
// BREAK
OVARIAN CANCER – PART I
Chair: A. du Bois, F. Hilpert
01.00 - 01.20 pm
Perioperative Management of Debulking Surgery in Advanced Ovarian Cancer
C. Fotopoulou
01.20 - 01.40 pm
Management of Lymphcysts / Complications of LNE Management
J. Sehouli
01.40 - 02.00 pm
The Ureter was Cut – What Can I Do Now?
L. M. Chiva de Agustin
02.00 - 02.20 pm
Management of Bowel Leakage
G. Aletti
02.20 - 02.40 pm
Management of Stoma Complications and Timing of Replacement
P. F. Alesina
02.40 - 03.00 pm
// BREAK
SATELLITE SYMPOSIUM
Chair: P. Harter, J. Sehouli
03.00 - 03.30 pm
Current Developments and Controversies in Ovarian and Endometrial Cancer – an International Perspective
Case Introduction: Ovarian Cancer
J. Sehouli
To Combine or Not to Combine – How to Choose 1L Maintenance in Ovarian Cancer?
A. González Martín
Panel Discussion
P. Harter, J. Sehouli
03.30 - 04.00 pm
Case Introduction: Endometrial Cancer
P. Harter
Advanced/Recurrent EC – What Options Do We Have?
M. R. Mirza
Panel Discussion
P. Harter, J. Sehouli
With the kind support of GlaxoSmithKline GmbH & Co. KG
OVARIAN CANCER – PART II
Chair: O. Zivanovic, A. González Martín
04.00 - 04.20 pm
Management of Thoracic Disease
D. S. Chi
04.20 - 04.40 pm
Treatment Choice in Recurrent Ovarian Cancer
J. A. Ledermann
04.40 - 05.00 pm
// BREAK
UTERINE CANCER – SPECIAL ISSUES
Chair: N. Colombo, N. Concin
05.00 - 05.20 pm
Cervical Cancer Surgery – Which Radicality for Which Stage
N. R. Abu-Rustum
05.20 - 05.40 pm
Treatment Options for Relapsed Cervical Cancer
N. Colombo
05.40 - 06.00 pm
Recurrent Endometrial Cancer
C. Marth
06.00 - 06.20 pm
Managing Toxicity of Combined Chemotherapy with Checkpoint Inhibitors and ADC in Gynecologic Oncology
D. Lorusso
06.20 - 06.40 pm
Most Promising New Agents in Gynecological Oncology
F. Marmé
SATURDAY, SEPTEMBER 9, 2023
MAIN PROGRAM: BREAST CANCER
EARLY BIRD SYMPOSIUM
Chair: S. Kümmel
08.15 - 09.00 am
An Underestimated Risk? Challenges in HR+ HER2- eBC from the Patient and Physician Perspective
Risk of Recurrence in the Adjuvant Setting: What Parameters Help us to Assess the Risk?
N. Harbeck
A Dialogue on Risk of Recurrence – Interview with Patient Representatives
Results from the NATALEE trial
S. Kümmel
With the kind support of Novartis Pharma GmbH
UPDATE ON SYSTEMIC TREATMENT IN BREAST CANCER:
WHAT IS PROVEN, WHAT IS COMING NEXT?
WHAT IS PROVEN, WHAT IS COMING NEXT?
Chair: S. Kümmel
09.00 - 09.20 am
Triple-Negative Breast Cancer – From Early to Metastatic Disease
P. Schmid
09.25 - 09.55 am
HER2/neu-Positive Disease – From Early to Metastatic Disease
R. Bartsch
10.00 - 10.20 am
HR-Positive Early Breast Cancer – Who Needs Chemotherapy?
O. Gluz
10.25 - 10.45 am
HR-Positive Metastatic Breast Cancer – Which Drugs
N. Harbeck
10.45 - 11.00 am
// BREAK
LOCAL THERAPY – AXILLA SURGERY
Chair: M. Reinisch, A. S. Caudle
11.00 - 11.20 am
De-Escalation in Axilla Surgery After NACT: Where are We and What is Coming in the Future?
A. S. Caudle
11.20 - 11.35 am
Sentinel – Is ICG Ready for Prime Time?
M. Reinisch
11.35 - 11.50 am
Lymphedema of the Arm: From Super Microsurgery to Liposuction C – What, When and How?
B. Behr
11.50 - 12.05 pm
Live Discussion and Live Chat
12.05 - 12.40 pm
// BREAK
ONCOPLASTIC SURGERY
Chair: F. Reyal, J.-U. Blohmer
12.45. - 01.10 pm
Hot Topics and Unsolved Questions in Oncoplastic Surgery
J. Heil
01.10 - 01.25 pm
Implant Wrinkling After Prepectoral Implant Reconstruction: How to Solve?
M. Reinisch
01.25 - 01.40 pm
Scar Treatment – Learn from the Best!
I. Stoffels
SCIENTIFIC SYMPOSIUM
Chair: S. Kümmel
01.40 - 02.40 pm
State of the Art and Recent Developments of ADC Technology in Breast Cancer
Welcome
S. Kümmel
Status Quo of ADC Therapy and Clinical Experience in HER2-low Metastatic Breast Cancer (mBC)
N. Harbeck
Recent Key Developments of ADC Technology in Breast Cancer
P. Schmid
Round-Table Discussion
With the kind support of Daiichi Sankyo Deutschland GmbH and AstraZeneca GmbH
02.40 - 03.10 pm
// BREAK
WHAT WE CAN LEARN FROM OTHER SUBJECTS?
Chair: M. Thill, C. Berliner
03.10 - 03.30 pm
Molecular Imaging and Therapy with Nuclear Medicine: Where are we in Breast Cancer?
C. Berliner
03.30 - 03.45 pm
How to Optimize Radiotherapy After Implant Placement to Minimize Capsular Fibrosis?
E. Karagiannis
03.45 - 04.00 pm
What Can we Learn from Melanoma Surgery?
J. Klode
| Status: August 2023; may be subject to change |